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Abstract: The molecular species of 1,2-diacyl-sn-glycerol 
(DAG), phosphatidylcholine (PC), phosphatidylethanolamine 
(PE), phosphatidylserine (PS), phosphatidylinositol (PI), 
phosphatidylinositol 4-phosphate (PIP), and phosphatidyl- 
inositol 4,5-bisphosphate (PIP2) from brains of adult rats 
(weighing 150 g) were determined. The DAG, isolated from 
brain lipid extracts by TLC, was benzoylated, and the mo- 
lecular species of the purified benzoylated derivatives were 
separated from each other by reverse-phase HPLC. The total 
amount and the concentration of each species were quantified 
by using 1,2-distearoyl-sn-glycerol ( 18:O- 18:O) as an internal 
standard. About 30 different molecular species containing 
different fatty acids at the sn-1 and sn-2 positions of DAG 
were identified in rat brains ( 1  min postmortem), and the 
predominant ones were 18:O-20:4 (35%), 16:O- 18: 1 ( 15%), 
I6:O- 16:O (9%), and 16:O-20:4 (8%). The molecular species 
of PC, PE, PS, and PI were determined by hydrolyzing the 
lipids with phospholipase C to DAG, which was then ben- 
zoylated and subjected to reverse-phase HPLC. PIP and PIP2 
were first dephosphorylated to PI with alkaline phosphatase 
before hydrolysis by phospholipase C. The molecular species 
composition of phosphoinositides showed predominantly the 
18:O-20:4 species (50% in PI and -65% in PIP and PIP2). 
PS contained mainly the 18:O-22:6 (42%) and 18:O-18: 1 (24%) 
species. PE was mainly composed of the 18:O-20:4 (22%), 18: 
0-22:6 ( IS%), 16:O- 18: 1 ( 15%), and 18:O- 18: 1 ( 15%) species. 
In PC the main molecular species were 16:O-18:l (36%), 16: 
0-1 6:O ( 19%), and 18:O- 18: 1 ( 14%). Studies on postmortem 
brains (30 s to 30 min) showed a rapid increase in the total 
amount (from 40-50 nmol/g in 0 min to 210-290 nmol/g 
in 30 min) and in all the molecular species of DAG. Com- 
paratively larger increases (seven- to l0-fold) were found for 
the 18:O-20:4 and 16:O-20:4 species. Comparison of DAG 
species with the molecular species of different glycerolipids 
indicated that the rapid postmortem increase in content of 
DAG was mainly due to the breakdown of phosphoinositides. 
However, a slow but continuous breakdown of PC to 
DAG was also observed. Key Words: 1,2-Diacyl-sn- 
glycerol - Phosphatidylcholine - Phosphatidylethanol- 
amine - Phosphatidylserine - Phosphatidylinositol- Phos- 
phatidylinositol phosphate-Phosphatidylinositol bisphos- 
phate-Rat-Brain. Lee C. and Hajra A. K. Molecular 
species of diacylglycerols and phosphoglycerides and the 
postmortem changes in the molecular species of diacylglyc- 
erols in rat brains. J. Neurochem. 56, 370-379 (199 1). 
Diacylglycerol ( 1,2-diacyl-sn-giycero1; DAG) has 
long been known as an important intermediate for 
glycerolipid biosynthesis in eukaryotic cells (Kennedy, 
1957). This biosynthetic precursor is formed in en- 
doplasmic reticulum by hydrolysis of phosphatidic acid 
(PA), and then it is converted to  triglycerides or phos- 
phoglycerides in the same subcellular compartment 
(Bell and Coleman, 1980). In recent years DAG has 
also been shown to be an important effector for a 
transmembrane signaling system elicited by different 
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hormones and neurotransmitters (Nishizuka, 1984, 
1986). It is postulated that plasma membrane phos- 
phoinositides are hydrolyzed to DAG by a receptor- 
mediated activation of phospholipase C and that this 
DAG, in turn, activates protein kinase C. DAG, gen- 
erated from inositides, has also been postulated to be 
the source of free arachidonic acid (20:4), which is the 
precursor of all eicosanoids (Prescott and Majerus, 
1983). These biomessenger roles of DAG were amply 
verified in several in vitro systems where phosphoino- 
Abbreviations used: DAG, 1,2diacyl-sn-glyceroI; PA, phosphatidic 
acid PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, 
phosphatidylinositol; PIP, phosphatidylinositol 4-phosphate; PIP2, 
phosphatidylinositol 4,5-bisphosphate; 4-PP, 4-pyrrolidinopyridine; 
PS, phosphatidylserine. 
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sitides were prelabeled by using different radioactive 
precursors and the radioactive products were analyzed 
(Nishizuka, 1986). An increase in the mass of DAG in 
different systems after stimulation by different ligands 
has also been demonstrated (Loeffelholz, 1989; Pelech 
and Vance, 1988). However, the source(s) and subcel- 
lular site(s) of such receptor-mediated generation of 
DAG have not been firmly established. Recently phos- 
phatidylcholine (PC) has been postulated to be the 
source of DAG in several signal-transducing systems 
(Exton, 1990). 
One way to distinguish such receptor-mediated for- 
mation and metabolism of DAG from de novo bio- 
synthetic DAG is to analyze the molecular species of 
DAG in these systems. The phosphoinositides in most 
systems have been shown to be comprised mostly (60- 
80%) of one single molecular species, i.e., l-stearoyl- 
2-arachidonoyl-sn-glycerol derivative, and therefore the 
DAG formed from inositides should consist of the same 
species. In contrast, the biosynthetic DAG or the DAG 
from sources other than inositides should contain dif- 
ferent fatty acids. Therefore, an analysis of the molec- 
ular species of DAG may provide some indications 
regarding its source and possible site of formation. This 
has been attempted by some workers who used a sen- 
sitive radiometric method in which the DAG was con- 
verted to 32P-phosphatidate by [32P]ATP in the pres- 
ence of either endogenous or exogenous DAG kinase 
and then the 32P-labeled phosphatidates (as dimethyl 
esters) were separated from each other by either argen- 
tation TLC or HPLC (Van Rooijen et al., 1985; Ken- 
nerly, 1987). However, a good separation of different 
molecular species of phosphatidate was not achieved 
by these methods. 
The present work was undertaken to develop a sen- 
sitive method for the quantitative analysis of molecular 
species of DAG in different biological systems. The 
methodology was based on the demonstration by sev- 
eral workers that reverse-phase HPLC could be used 
for good resolution of different molecular species of 
DAG (generated from hydrolysis of phosphoglycerides 
by phospholipase C) after acylation to the acetyl (Na- 
kagawa and Horrocks, 1983), benzoyl (Blank et al., 
1984), or other derivatives (Batley et al., 1980; Krueger 
et al., 1984). We have adapted these methods, especially 
that described for the reverse-phase HPLC separation 
of benzoyl DAG, and used an internal standard to 
quantify different molecular species of DAG present 
in rat brain. 
DAG has been shown to be present in small quan- 
tities in brain, and it has been shown that there is a 
rapid postmortem increase in its amount in brain 
(Banschbach and Geison, 1974; Aveldano and Bazan, 
1975; Ikeda et al., 1986). A preponderance of 18:O and 
20:4 fatty acids in this DAG indicated that the rapid 
postmortem increase in its level was probably due to 
the hydrolysis of brain phosphoinositides. We have 
verified this directly by quantifying the postmortem 
changes in the molecular species of rat brain DAG and 
also have analyzed the molecular species of different 
phosphoglycerides, including the inositides. These re- 
sults are presented here. 
MATERIALS AND METHODS 
Materials 
Sprague-Dawley rats (5 weeks old, weighing 150-160 g) 
were obtained from Harlan Laboratories (Indianapolis, IN, 
U.S.A.). Benzoic anhydride, 4-pyrrolidinopyridine (CPP), 
I ,2-distearoyl-sn-glycerol, phospholipase C (Baciflus cereus), 
and calf intestine alkaline phosphatase were obtained from 
Sigma Chemical Co. (St. Louis, MO, U.S.A.). PUFA-2, a 
GLC standard mixture of polyunsaturated fatty acids, was 
obtained from Supelco (Bellefonte, PA, U.S.A.). All the sol- 
vents for HPLC were HPLC grade, and other solvents were 
chemical grade. TLC plates (silica gel 60) were purchased 
from Merck (Cherry Hill, NJ, U.S.A.). Dry benzene was pre- 
pared by distilling it from calcium hydride. I-Stearoyl-2- 
[5,6,8,9,11,12,14, 15-3H]arachidonoyl-sn-glycerophosphoryl 
choline was purchased from NEN-Dupont (Boston, MA). 
Extraction and purification of DAG 
Rats were anesthetized with diethyl ether, and their fore- 
brains (cerebrum and cerebellum) were quickly excised and 
homogenized in chloroform/methanol ( I : 1, I2 ml/g of tissue) 
with a Polytron (Brinkmann) homogenizer. A known amount 
(-30 nmol/g of brain) of internal standard, i.e., 1 ,f-distea- 
royl-sn-glycerol, was added to the homogenate. The homog- 
enate was centrifuged at low speed (1,000 g, 10 min), and 
the supernatant was saved. The residue was dispersed in water 
(0.5 ml/g of tissue) by agitation in a sonic bath, and this 
dispersion was rehomogenized in chloroform/methanol ( 1 : 
1, 6 ml/g of original tissue). This second homogenate was 
centrifuged (1,000 g, LO min), the supernatant was combined 
with the first supernatant, and the residue was saved for acidic 
extraction (see below). To the combined supernatants, an 
additional amount of chloroform was added (9 ml/g of tissue) 
and mixed well, and 0.9% aqueous NaCl(5.5 ml/g of tissue) 
was added to the extract to separate the phases (Folch et al., 
1957). The mixture was vortex-mixed and centrifuged (1,000 
g, 5 min), and the upper layer was removed. The lower layer 
was dried in a rotary evaporator, and the residue was dissolved 
in chloroform (3.5 ml/g of tissue) and, when necessary, stored 
at -20°C under nitrogen. This lipid extract by a neutral sol- 
vent mixture was spotted on a 20- X 20-cm TLC plate (Merck 
silica gel 60, 0.25 mm thick) as a band (lipid extract from 
-I0 mg of tissue/cm), and the plate was developed with 
toluene/ether/methanol (80: 10: 10 by volume) up to 10 cm 
from the origin. The DAG band (Rf = 0.60) was identified 
by comparison with the standard DAG chromatographed 
side-by-side after spraying with Primuline (0.00 1%) (Wright, 
197 I )  and viewing under UV light. The band was scraped 
off, and the DAG was extracted three times from TLC powder 
with 2 ml of diethyl ether by sonication for 30 s followed by 
centrifugation (1,000 g, 5 min). The ether was removed by 
blowing NZ, and the DAG was used immediately for ben- 
zoylation. 
Purification of other lipids 
Phospholipids [PC, phosphatidylethanolamine (PE), 
phosphatidylserine (PS), and phosphatidylinositol (PI)] pres- 
ent in the neutral extract were separated from each other by 
TLC using two developments in the solvent system of chlo- 
roform/methanol/0.25% KCl/ethyl acetateln-propanol (30: 
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9:6:18:25 by volume) (Hedegaard and Jensen, 1981). The 
bands were visualized by spraying with Primuline and iden- 
tified by comparison with authentic standards (chromato- 
graphed side-by-side). The bands were scraped off, and the 
lipids were extracted from the powders with either chloro- 
form/methanol (2: 1 vol/vol) for PC, PS, and PE or chloro- 
form/methanol (2:l vol/vol) containing 0.25% HCI for PI. 
The HCI was removed by adding 0.25 volume of water to 
the extract to separate the phases, the upper layer was re- 
moved, and the lower layer was dried by blowing N2. 
Polyphosphoinositides were isolated from the tissue resi- 
dues, left after neutral chloroform/methanol extraction, by 
extracting with chloroform/methanol/12 M HCI (200: 100: 
0.75 by volume, 16 ml/g of brain) and centrifuged, and the 
supernatant was transferred to another tube. To the super- 
natant 0.25 volume of 1 M HCl was added, mixed well, and 
centrifuged. The upper layer was removed, and the lower 
phase was washed once with Folch upper phase (Folch et al., 
1957) and then evaporated to dryness by blowing Nz. The 
residue was dissolved in 2 ml of chloroform/methanol/water 
(75:25:2 by volume), and the extract was spotted as a band 
on a TLC plate impregnated with 1.2% potassium oxalate 
(Hajra et al., 1988). The plate was developed with chloroform/ 
methanol/7.4 M NH40H/water (40:48:5: 10 by volume) fol- 
lowed by n-propanol/7.4 M NH,OH/water (65:20: 15 by vol- 
ume) (Grove et al., 198 1). Bands were localized after spraying 
with Primuline, and the bands containing PI 4-phosphate 
(PIP) and PI 4,5-bisphosphate (PIP2) were extracted from the 
TLC scrapings by dispersing them three times with 10 ml of 
chloroform/methanol/ 12 MHCl(66.6:33.3:0.25 by volume). 
To the combined extracts 0.25 volume of water was added, 
mixed well, and centrifuged, and the upper layer was re- 
moved. The lower layer was filtered through a PTFE filter 
(pore size, 0.45 pm) to remove insoluble material, and the 
solvents were removed under Nz. The dried PIP and PIP2 
residues were subjected to enzymatic dephosphorylation to 
convert them to PI as described below. 
Hydrolysis with alkaline phosphatase 
PIP and PIPz are not hydrolyzed by bacterial phospholipase 
C, and, therefore, these lipids were first dephosphorylated to 
PI, which could then be converted to DAG. PIP and PIPz 
were hydrolyzed to PI by alkaline phosphatase by the method 
of Ehle et al. (1985). The lipids were dried down under Nz 
in Reacti-Vials (Pierce Chemical Co.) and then magnetically 
stirred in a reaction mixture (final volume, 0.5 ml) containing 
10 mM Tris-HC1 buffer (pH 7.4), sodium deoxycholate (3 
mM), and alkaline phosphatase (2 U) for 6 h at 37°C. The 
reaction was stopped by adding 5.0 ml of chloroform/meth- 
anol(2: 1 vol/vol) followed by 1 ml of 1 A4 HCl. After mixing 
and centrifuging, the lower layer was transferred to another 
tube and dried under N2, and the PI formed was purified by 
TLC as described above. 
Phospholipase C hydrolysis 
PC, PI, PS, and PE were sonicated with 0.30 ml of 0.25% 
Triton X-100 in 50 mMTris-HC1 buffer (pH 7.9, and these 
mixed micelles were then incubated with 10 U of phospho- 
lipase C (from B. cereus) at 37°C for 6 h (Sundler et al., 
1978). The reaction was terminated by chloroform/methanol/ 
1 M HCI as described above, and the DAG from the lower 
layer was purified by TLC (toluene/ether/methanol80: 10: 10 
by volume). Authentic standard l-~tearoyl-2-[~H]arachi- 
donoyl-sn-glycerol-3-phosphocholine was converted to the 
corresponding [3H]DAG by using the same procedure. 
Benzoylation of DAG 
The purified DAG in dry ether was quantitatively trans- 
ferred to a Reacti-Vial with dry ether, and the solvent was 
removed by blowing N2. To the dry DAG (- 10-40 nmol) 
100 p1 of dry benzene and 20 pl of a solution containing 6.8 
pmol of 4-PP and 5.5 pmol of benzoic anhydride in dry ben- 
zene were added, and the mixture was magnetically stirred 
under NZ at room temperature for 1 h. The reaction was 
stopped by adding 0.1 ml of methanol, and the mixture was 
stirred for another 5 min. The mixture was then spotted on 
TLC plates as a band and developed with hexane/diethyl 
ether/7.4 M N h O H  (55:45: 1 by volume). The benzoyl DAG 
band (R,  = 0.65) was scraped off, extracted three times with 
2 ml of ether, and used for purification by HPLC. 
Purification of benzoyl DAG by normal-phase HPLC 
The normal-phase HPLC was performed using a Waters 
M-45 stainless steel solvent delivery system and a silica gel 
column (25 X 0.46 cm; pore size, 5 pm; Rainin) attached to 
a Spectroflow Kratos 773 UV monitoring system. The ben- 
zoyl DAG sample in ether was filtered through a PTFE filter 
(pore size, 0.45 pm) to remove particulate matter, and the 
solvent was removed by blowing NZ. The residue was dis- 
solved in cyclohexane, and a 2 0 4  aliquot was injected into 
the column. Benzoyl DAG was eluted isocratically using cy- 
clohexane/ether (96.3:3.7 vol/vol) at a flow rate of 1 ml/min 
at room temperature. The elution was monitored at 228 nm, 
and the benzoyl DAG peak was collected and dried un- 
der Nz. 
Separation of molecular species of DAG 
The DAG fraction collected from normal-phase HPLC 
was dried, dissolved in acetonitrile, and injected into an oc- 
tadecyl silica gel reverse-phase column (25 X 0.46 cm; 
Rainin). The molecular species were eluted isocratically using 
acetonitrile/isopropanol (70:30 vol/vol) at a flow rate of 1 
ml/min at room temperature. The eluate was monitored at 
228 nm, and the peak areas were integrated using a Nelson 
analytical PC integrator with a 900 series interface attached 
to the monitoring system. 
Identification of reverse-phase HPLC peaks by GLC 
For the purpose of identification, each peak collected from 
the HPLC column was dried and methanolyzed by heating 
for 15 min at 60°C with 0.5 ml of 13% BF3 in methanol. 
Two milliliters of hexane and I .5 ml of water were added to 
the mixture, mixed well, and centrifuged. The upper hexane 
layer was transferred to another tube, and the lower layer 
was extracted two more times with 2 ml of hexane. The com- 
bined hexane layers after washing with water were dried under 
Nz, dissolved in a small volume of dichloromethane, and 
injected into the gas chromatographic column. 
The gas chromatography was performed using a Hewlett- 
Packard gas chromatograph (model 5800) equipped with a 
fused silica capillary column (30 m X 0.2 mm) coated with 
SP 2330 (cyanopropyl silicone from Supelco) and a flame 
ionization detector. The camer gas was helium, and the area 
under each peak was determined using a Hewlett-Packard 
integrator (model 3396A). The peaks were identified by com- 
paring the retention values with those of known standards. 
Postmortem changes in the molecular species 
of DAG 
To analyze the changes of molecular species and amounts 
of DAG, the rats were lightly anesthetized with ether. For 
the zero-time points, the skull was opened, and the brain was 
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excised with a spatula and immediately (< 10 s) dropped into 
liquid Nz. For the time course study, the rats were decapitated, 
and the whole heads were opened, put into plastic bags, and 
incubated at 37°C ( > I  min time course) for the indicated 
interval (0.5, 1.0, 3.0, 12, and 30 min). After incubation, the 
brains were rapidly excised from the heads and dropped im- 
mediately into liquid nitrogen. The frozen brains were ho- 
mogenized in chlorofo~m/methanol, and the DAG was iso- 
lated from the extracts as described above. 
RESULTS 
Purification of DAG 
DAG (Rf = 0.6) migrated just above the wide cho- 
lesterol band (Rf = 0.5) and was well separated from 
other neutral lipids or free fatty acid (Rf = 0.36) in the 
solvent system used for TLC. Recovery of DAG from 
brain extract was -80435% (Table 1). Alkyl and al- 
kenyl acyl glycerol, if present, were located just above 
the DAG band. 
Conversion of different phospholipids to DAG 
PC, PS, PI, and PE had Rf  values of 0.15 ,0 .22 ,0 .28 ,  
and 0.50, respectively, in the TLC system used. PIP 
and PIPz had Rf  values of 0.21 and 0.33, respectively, 
in the TLC system used for the oxalated plates. By 
TLC examination, it was found that the conversion of 
PIP and PIP2 to PI by alkaline phosphatase was com- 
plete. By TLC analysis, it was also found that phos- 
pholipase C from B. cereus completely hydrolyzed all 
phospholipids. The phospholipase C from Clostridium 
perfringens did not hydrolyze PI but hydrolyzed other 
lipids. 
Benzoylation of DAG and purification of 
benzoyl DAG 
The benzoylation reaction using 4-PP as the catalyst 
went to completion within 1 h (Fig. 1). After the re- 
action, the excess benzoic anhydride was converted to 
methyl benzoate by addition of methanol, and the 
benzoyl DAG was purified by TLC. In the TLC system 
used, the benzoyl DAG had an Rf value of 0.65, well 
separated from both methyl benzoate (R, = 0.9) and 
the catalyst (Rf = 0). The recovery of the benzoyl DAG 
after benzoylation and TLC was -90% (Table 1). 
Benzoyl DAG was further purified by normal-phase 
HPLC to remove impurities extracted from TLC plates 
and also to remove small amounts of ether analogs of 
DAG if they were present. In the HPLC system used, 
the benzoyl DAG was eluted out as a single peak with 
a retention time of 13 min. In this system the benzoyl 
derivative of alkyl acyl glycerol had an Rf  value of 6.7 
min, and that for alkenyl acyl glycerol was 5.6 min. 
The presence of ether analogs was noted when DAG 
was derived from phosphoglycerides, especially from 
PE. Very little, if any, of the ether analogs of DAG was 
present in the TLC and HPLC systems used for the 
isolation of free DAG. 
Separation and identification of molecular species 
of DAG 
The elution profile of purified brain benzoyl DAG 
from the reverse-phase HPLC column is shown in Fig. 
2. There are a total of 18 peaks plus the peak for the 
internal standard, i.e., benzoylated distearoyl glycerol. 
This chromatogram was typical of the brain DAG pro- 
file obtained 1-2 min after decapitation (see below). 
From the total area under all the peaks and from the 
amount of the 1,2-distearoyl-sn-glycerol added as the 
internal standard and the area of that peak (Fig. 2), it 
was calculated that the amount of DAG present was 
98 nmol/g of brain for that particular experiment (Ta- 
ble 2). 
The peaks were identified by collecting each one 
from the eluate and then analyzing the fatty acids re- 
leased after methanolysis by gas chromatography. Peaks 
containing a single molecular species, e.g., peak 10, 
were easily identified by the 1:  1 molar proportion of 
two fatty acids seen after gas chromatography. Peaks 
containing multiple molecular species, e.g., peak 8, 
were identified by the molar proportions of different 
fatty acids seen after gas chromatography and also by 
plotting the relative retention time with the effective 
TABLE 1. Recovery of labeled DAG at each step of analysis 
Experiment 'A Experiment B 
Sample 
Radioactivity Recovery Radioactivity Recovery 
(cpm) (S) kumt (%f 
Brain extract 3.34 x 105 100 3.34 x 105 100 
After first TLC 2.71 x 105 81.3 2.81 x 105 84.2 
After second TLC 2.51 X lo5 92.4 2.54 x 105 90.3 
DAG peak from normal-phase HPLC 2.39 x 105 95.3 2.47 X 10' 97.1 
Overall yield 70.9 13.8 
18:O-20:4 peak from reverse-phase HPLC 2.37 x 105 99.2 2.48 x 105 100 
To the total brain lipid extract a trace amount of 1-stearoyl-2-[5,6,8,9,11,12,14,1 5-3H]archidonoyl-sn-glycerol was 
added, and the extract was analyzed for different molecular species of DAG as described in the text. Radioactivity in 
the aliquots at each stage of purification and in the final HPLC eluate (peak 10 in Fig. 2) was determined. These counts, 
after correction for the counts taken out in the aliquots, are presented here. 
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FIG. 1. Time course of benzoylation of DAG with benzoic anhy- 
dride. Total DAG (-100 nmol) from one rat brain containing a 
tracer amount of l-stearoyl-2-[5.6,8,9,11.12,14.1 5-3H]arachi- 
donoyl-sn-glycerol(2.76 X 1 O5 cpm) was benzoylated with benzoic 
anhydride using 4-PP as the catalyst in dry benzene (total volume, 
450 pl) as described in the text. At the indicated times, 30 pl of 
the reaction mixture was taken out and spotted on a TLC plate, 
which was developed in hexane/ether/NH,OH (55:45:1 by volume). 
The spots corresponding to DAG (R, = 0.60) and benzoyl DAG (R, 
= 0.65) were scraped out, and the radioactivity in the scrapings 
was determined. The result was given as the percentage of radio- 
activity present in the benzoyl DAG fraction. Duplicate experiment 
showed less than approximately k5O/0 variability at the initial in- 
tervals (<20 min). 
profiles obtained for PI and PIP2, which were quite 
different from that for PC, are shown in Figs. 4 and 5, 
respectively. The peaks are numbered the same way as 
in Fig. 2, and their identities are the same as in Table 
2. The relative amount (in mol%) of each peak is given 
in Table 3. Table 3 also shows the percent composition 
of molecular species for PE and PS. 
Postmortem changes in the molecular species 
of DAG 
The postmortem increase in the total amount of 
brain DAG, calculated from the amount of internal 
standard recovered after HPLC separation, is shown 
in Fig. 6. Although the amounts of all DAG species 
increased, this increase was more pronounced for some 
species than others. The changes in the major molecular 
species are shown in Fig. 7. The postmortem changes 
of both relative and absolute amount of each peak as 
analyzed by HPLC are shown in Table 4. 
DISCUSSION 
Derivatives of DAGs, obtained after phospholipase 
C hydrolysis of different phospholipids, have been used 
by different researchers to analyze the molecular species 
of phosphoglycerides (Batley et al., 1980; Nakagawa 
and Horrocks, 1983; Blanket al., 1984; Krueger et al., 
1984). We found that the acetyl and benzoyl derivatives 
of DAG were well-suited for the separation of all the 
molecular species of brain DAG by reverse-phase 
HPLC. The benzoyl derivatives, as reported by Blank 
et al. ( 1984), were chosen for such separation because 
of the high absorbance of the benzoyl group ( I  .3 X lo4 
gardless of their fatty acid compositions. Several mod- 
ifications of the published method were made, which 
included the use of relatively nontoxic solvents for 
carbon number by the method of Patton et al. (1 982). 
The position assigned for the fatty acids at the sn-1 
and sn-2 position of the glycerol moiety is arbitrary, 
with the assumption that the more saturated one is 
present at C- 1. 
with the amount 
present for a typical chromatogram are given in Table 
0-20:4 (peak lo), 16:O-16:0 (peak 13), and 16:O-18:l 
(peak 12; this peak was mixed with other minute com- 
ponents) (Fig. 2 and Table 2). 
The identities Of each peak 
2. The major peaks Seen were 16:0-20:4 (peak 5 ) ?  18:  M-1 cm-l), which was the Same for all the species re- 
Molecular species of brain phosphoglycerides 
The HPLC elution profile of the DAG (benzoylated) 
obtained from total brain PC is shown in Fig. 3. Elution 
TLC, a different catalyst (4-PP) for benzoylation, and 
an internal standard ( 1,2-distearoyl-sn-glycerol) for 
quantification. A different catalyst was used, because 
FIG. 2. Separation profile of benzoyl DAG by 
reverse-phase HPLC. DAG isolated from rat 
brains (1 min postmortem) containing the added 
internal standard, 1,2distearoyl~n-glycerol(30 
nmol/g brain), was benzoylated, purified, and 
subjected to reverse-phase HPLC as described 
in the text. A total of -20 nmol of benzoyl 
DAG was injected into the HPLC column. The 
detector output (Azz8) versus time is plotted 
here. The composition of each numbered peak 
is given in Table 2. 
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Total rat brain DAG, after isolation by TLC, was benzoylated, 
purified, and subjected to HPLC as described in the text. The peak 
numbers correspond to the separation profile as presented in Fig. 2. 
Each peak from the HPLC column was collected, and its fatty acid 
composition was determined by GLC analysis as described in the 
text. When more than one species of DAG was present in the peak 
(more than two fatty acids), the assignment of species was done from 
the ratio of each fatty acid and the hydrophobicity of each species as 
described in the text. In the identified peaks the first number indicates 
the length of the carbon chain and the second the number of double 
bonds in the chain. In the assignment of the position of the fatty 
acid, it was arbitrarily assumed that the more unsaturated fatty acid 
was positioned at C-2. Tr, trace. 
in our tests, 4-PP proved to be more effective than 
dimethylaminopyridine in terms of complete acylation 
of DAG in a shorter interval without any migration of 
the acyl groups. Distearoyl glycerol was used as the 
internal standard, because this moiety is virtually ab- 
sent from tissue glycerides, and on HPLC it did not 
overlap with any other molecular species. The use of 
a fully saturated internal standard, however, raised the 
question of properly compensating for the loss of spe- 
cies containing unsaturated fatty acyl moieties during 
the purification of DAG. However, when tested, the 
total recovery of a species containing highly unsatu- 
I I I I I I 
0 I0 20 30 40 
TIME ( m i d  
FIG. 3. Molecular species profile of rat brain PC. Rat brain PC 
was hydrolyzed with phospholipase C, and the resulting DAG was 
benzoylated, purified, and subjected to HPLC separation as de- 
scribed in the text. About 200 nmol of benzoyl derivatives obtained 
from PC was injected into the HPLC column. The peak numbers 
correspond to the same numbers as in Fig. 2. 
rated 20:4 (Table 1) was fairly close to the recovery of 
distearoyl glycerol (72 vs. 73%), a result indicating that 
the comparative loss of DAG containing polyunsatu- 
rated fatty acids was <2%. The loss of unsaturated 
0.: 
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FIG. 4. HPLC separation profile of molecular species of PI in rat 
brain. Rat brain (1 min postmortem) PI was isolated and hydrolyzed 
to DAG, which was then benzoylated, and the molecular species 
were separated from each other by reverse-phase HPLC as de- 
scribed in the text. About 100 nmol of benzoyl DAG obtained from 
PI was injected into the HPLC column. The numberings correspond 
to those of the HPLC profile shown in Fig. 2 and Table 2. 
J. Neurochem., Vol. 56, No. 2, 1991 
3 76 C. LEE AND A .  K.  HAJRA 
w V





I 5 I 
0 10 20 30 40 
TIME ( m i n l  
FIG. 5. HPLC separation profile of molecular species of PIPp in 
rat brain. Rat brain PIP2 was isolated, dephosphorylated to PI, and 
hydrolyzed to DAG. which was then benzoylated and used for 
HPLC separation as described in the text. Ten nanomoles of ben- 
zoyl DAG obtained from PIP2 was used for the separation. The 
numberings correspond to Fig. 2 and Table 2. 
moieties was minimized by rapid processing and, when 
feasible, conducting the operations under a N2 atmo- 
sphere. The rapid processing also prevented any acyl 
migration ( 1,2-diacylglycerol to 1,3-diacylglyceroI) be- 
fore the benzoylation step. If the crude lipid extract or 
purified DAG was stored for long intervals, especially 
above pH 7, acyl migration occurred, as seen by the 
presence of the 1,3-isomers as shoulders to the 1,2- 
diacyl peaks in the HPLC separation profile. 
The validity of the internal standard method of 
quantification has been verified against two other 
quantitative methods. Similar amounts of DAG were 
obtained when measurements were made after acety- 
lation of the purified DAG with ['4C]acetic anhydride 
of known specific activity (D. DeMarais, C .  Lee, and 
A. K. Hajra, unpublished data). Also, with the TLC- 
purified DAG, similar results were obtained when en- 
zymatic phosphorylation by [y3*P]ATP, as described 
by Preiss et al. (1986), was used in two experiments 
(93 and 96 nmol/g of brain as estimated by the above 
HPLC method vs. 93 and 91 nmol/g of brain when 
the enzymatic method was used).' 
The molecular species composition of DAG (Fig. 1 
and Table 2) reveals that 18:O-20:4 (peak 10) is the 
I We found that for the enzymatic estimation, DAG from total 
brain lipid extract should be first purified before phosphorylating 
with ATP using DAG kinase (Lipidex). When the measurement was 
done using total brain lipid extract, the amount of DAG was two- 
to threefold higher than that determined by the benzoylation or acet- 
ylation reactions. These high values were probably due to the presence 
of PA phosphataw in the commercial DAG k i n a  (crude Escherichia 
coli membranes), which hydrolyzes the large amounts of PA present 
in the brain lipid extracts to DAG. TLC purification of DAG removed 
the PA, and reproducible results were obtained using the enzymatic 
phosphorylation method. 
TABLE 3. Distribution profile of the individual molecular 
species PI, PIP, PIP2, PC, PE, and PS 
Peak PI PIP PIP* PC PE PS 
1 0.18 0.09 Tr 0.46 1.01 0.14 
2 1.43 0.55 0.15 3.35 4.85 0.80 
3 0.09 0.10 0.54 Tr Tr 0.34 
4 3.87 4.09 4.35 0.95 2.92 0.10 
5 7.84 9.38 9.54 4.42 2.30 0.61 
Tr Tr Tr Tr 0.26 0.22 6 
7a" 1.52 1.09 
4.08 2.49 17.62 42.40 
7b" 1.20 0.96 
8 0.59 0.82 0.38 3.06 1.47 0.78 
9 0.96 1.12 0.69 0.42 0.24 5.27 
10 49.52 63.72 66.13 3.84 22.49 3.76 
I I  1.67 4.49 2.14 3.43 11.10 7.01 
12 12.67 5.94 6.54 36.18 15.80 9.07 
13 6.90 1.22 1.37 19.17 0.68 Tr 
14 0.32 0.12 0.11 0.94 0.52 Tr 
15 0.40 0.49 0.40 0.91 1.41 2.48 
16 7.04 4.15 4.60 14.13 14.85 23.67 
17 1.96 0.93 0.98 5.38 1.19 Tr 
18 0.50 Tr Tr 0.71 1.30 2.22 
Data are mol% of each molecular species. Peak numbers match 
with those in Figs. 2-4. Tr, trace. 
For PI, PC, PE, and PS, 7b appeared as a shoulder on peak 7a 
and was not resolved from the larger peak. Therefore, these values 
represent combined 7a and 7b. 
main component, a finding indicating that inositides 
are the precursor for this species. However, peaks cor- 
responding to other lipids (mainly PC), such as 12 
(16:O-18:l) and 13 (16:O-16:0), are also present. The 
molecular species composition agrees well with the fatty 
acid composition of rat or mouse brain DAG reported 
from different laboratories (Sun, 1970; Aveldano and 
Bazan, 1975; Ikeda et al., 1986). From the fatty acid 
P 
I I I 
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TIME (min) 
FIG. 6. Postmortem increase in amount of total DAG in rat brain. 
DAG was isolated, benzoylated, and then subjected to HPLC as 
described in the text. The total amount (average of two experi- 
ments, which were within 5% of each other) was calculated from 
the areas under the peaks and comparable area under the internal 
standard (1 8:O-18:O) peak. 
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FIG. 7. Postmortem changes in the molecular species of rat brain 
DAG. Anesthetized rats were decapitated, and the brain DAG was 
extracted and analyzed at different intervals as described in the 
text. The changes of the amount of major DAG species in rat brain 
are shown: 18:O-20:4 (A), 16:O-20:4 (@), 16:0-18:1 (A), 18:0-18:1 
(0), 18:O-22:6 (D), and 16:O-16:0 (0). 
compositions, however, the actual molecular species 
of different lipids could not be accurately inferred. For 
example, it is generally assumed that all the stearic acid 
corresponds only to the arachidonate at C-2, which 
leads to overestimation of the 18:O-20:4 species. As 
seen in Fig. 2, although 18:O-20:4 is the major one, 
there are other arachidonate-containing species, such 
as 16:O-20:4 (peak 5; 8%) and 18:l-20:4 (peak 4; 4%). 
Similarly, there are several species containing stearic 
acid (peaks 10-1 8) but no arachidonic acid (see Table 
2). Therefore, it is not possible to deduce such a com- 
plex molecular composition of DAG or other lipids 
from the total fatty acid composition of the lipids. 
The HPLC method, which separated different mo- 
lecular species of benzoyl DAG very well, was used to 
analyze the molecular species of most brain phos- 
phoglycerides (diacyl species), which was not done be- 
fore. As shown in Table 3, qualitatively the same mo- 
lecular species are present in all phosphoglycerides and 
DAG. However, their quantitative compositions were 
quite different from one class of lipid to another. For 
example, in PS and PE (especially in PS), the species 
containing 22% (peak 7) was present in large amounts 
but was practically absent in PC. On the other hand, 
the dipalmitoyl moiety (peak 13) was present in large 
amounts in PC but not in PS or PE (Table 3). As ex- 
pected, the 18:O-20:4 species was the predominant one 
in the inositides. However, although the compositions 
of PIP and PIP2 were very close to one another, indi- 
cating a precursor-product relationship, the compo- 
sition of PI was somewhat different (Table 3). PI con- 
tained comparatively greater proportions of peaks 12, 
13, and 16, which consisted mainly of saturated and 
monounsaturated fatty acids (Table 2). This difference 
in composition of PI from PIP and PIP2 probably re- 
flects the fact that the fatty acid composition of de novo 
biosynthetic PI is mainly saturated and monounsatu- 
rated, which is later tailored to the 18:O-20:4 and similar 
species (Holub and Kuksis, 1978). This latter PI pool 
(in the plasma membrane?) is probably the precursor 
of PIP and PIP2. Another finding of potential interest 
TABLE 4. Postmortem channes in the total and individual amount of rat brain DAG 
-~ ~ 
0 rnin" 0.5 min 1 min 12 min 30 rnin 
Peak nmol/g % nmol/g % nmol/g % nmol/g % nmol/g % 
~~ 
1 0.17 0.37 0.26 0.44 1.25 I .36 0.85 0.48 2.50 1 .oo 
2 1.64 3.63 1.81 3.10 2.93 3.18 5.22 2.93 12.31 4.93 
3 0.33 0.73 Tr Tr Tr Tr 0.16 0.09 0.25 0.10 
4 1.19 2.64 1.49 2.54 3.18 3.45 3.42 I .92 6.74 2.70 
5 2.57 5.70 4.19 7.16 5.66 6.15 10.03 5.63 17.03 6.82 
6 Tr Tr 0.23 0.39 Tr Tr Tr Tr Tr Tr 
7 1.21 2.69 1.08 1.85 2.32 2.52 5.57 3.13 10.84 4.34 
8 2.26 5.00 1.57 2.68 3.00 3.21 4.02 2.26 6.67 2.67 
9 1.49 3.31 1.79 3.06 I .44 1.56 3.35 1.88 5.69 2.28 
10 9.82 21.78 19.1 1 32.67 3 3.07 35.91 6 1.99 34.81 92.90 37.21 
11 1.39 3.09 1.47 2.5 I 4.59 4.99 6.02 3.38 7.02 2.81 
12 9.58 2 1.24 10.34 17.68 16.20 17.59 38.52 21.63 45.76 18.33 
13 6.88 15.26 7.39 12.63 7.90 8.58 15.97 8.97 19.15 7.67 
14 Tr Tr 0.50 0.86 Tr Tr Tr Tr 0.22 0.09 
15 0.32 0.71 0.47 0.81 0.99 1.08 1.60 0.90 1.37 0.55 
16 2.05 4.55 2.18 3.72 4.50 4.89 10.63 5.97 10.96 4.39 
17 3.93 8.7 1 4.43 7.58 5.07 5.5 1 10.03 5.63 10.26 4.11 
18 0.24 0.54 0.12 0.20 Tr Tr 0.16 0.09 Tr Tr 
Total 45.1 I 58.50 92.08 177.52 249.67 
At each interval, the first column is the concentration (nmol/g of brain), and the second column is the mol% of the individual molecular 
species. Peak numbers correspond to those in Fig. 2. Tr, trace. 
The actual time may be - 10-15 s postmortem. 
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FIG. 8. Relative changes in amount of some individual DAG mo- 
lecular species in rat brain. The relative amounts of m e  molecular 
species of DAG at each time point compared with the amount 
present at zero-time are plotted: 18:O-20:4 (0). 16:O-20:4 (O), 16: 
0-16:0 (D), and 16:O-18:l (0). 
is that although brain PE and PS compositions are 
similar (Table 3), indicative of a precursor-product re- 
lationship, a much larger amount of 225 (peak 7a) 
and much lesser amount of 20:4 (peak 10) are present 
in PS than in PE. This may be due to compartmen- 
tation of different molecular species of PE and the for- 
mation of PS from PE in a particular compartment by 
the base exchange reaction. 
The rapid postmortem increase in amount of DAG 
(Fig. 7) is similar to those reported by other authors 
(Banschbach and Geison, 1974; Ikeda et al., 1986). 
From the fatty acid analysis of the DAG formed, it is 
generally believed that this rapid increase in the con- 
centration of DAG is entirely due to the breakdown 
of inositides. However, analysis of the molecular species 
indicated that not only the inositides but also PC was 
breaking down to DAG, albeit at a different rate. The 
species from inositides such as 16:O-20:4 and 18:O-20: 
4 rapidly increased in content within 1-3 min after 
death, whereas those coming from PC, e.g., 16:O- 18: 1. 
also increased in content but at a slower rate. This was 
clearly seen when the relative rates of increase of dif- 
ferent species were considered (Fig. 8). As seen in Fig. 
8, there is a rapid increase in content of 18:O-20:4 and 
16:O-20:4 in the first 2 min followed by a relatively 
slower rate of increase for these two species, which are 
typical for inositol-containing lipids. There was a si- 
multaneous rapid postmortem decrease in content of 
PIP and PIP2 (Dawson and Eichberg, 1965; Ikeda et 
al., 1986; authors' unpublished data), a result indicating 
a phospholipase C-mediated breakdown of these lipids. 
A slower but steady and parallel rate of increase in 
content of 16:O- 18: 1 and 16:O- 16:O species, which are 
typical of brain PC (Table 3), is seen, which indicates 
that there is also a postmortem breakdown of brain 
PC to DAG. 
The present work was undertaken to establish 
whether or not the source and nature of DAG formed 
in a biological system could be determined by analyzing 
the molecular species of DAG in different biological 
systems so that the messenger and biosynthetic roles 
of DAG are delineated. The method presented here is 
fairly sensitive, so that 3-5 nmol of total DAG (300 
pmol of individual components) can be quantitatively 
measured in tissues or in incubation mixtures. The 
method is tested by studying the postmortem changes 
of molecular species of DAG in brain, and, as shown 
here, specific lipids are found to break down at different 
rates to form DAG. The results are, of course, not easily 
interpreted with respect to actual source and com- 
partments where these transformations have taken 
place, because whole brain constitutes several different 
cell types and subcellular compartments. Using specific 
cell types and/or subcellular fractions might yield better 
results with respect to the precursor-product relation- 
ship of DAG and specific lipids and also the metabolic 
fate of the DAG formed. We have used this method 
to study the formation of DAG in SK-N-SH neuro- 
blastoma cells after muscarinic stimulation and ob- 
tained results showing a rapid formation of DAG from 
inositides but not from PC in these cells (C. Lee, S. K. 
Fisher, B. W. Agranoff, and A. K. Hajra, manuscript 
in preparation). These and other studies are in progress 
in our laboratory to study the detailed mechanisms of 
formation and turnover of DAG, which acts both as a 
precursor of lipids and as an effector of signal trans- 
ductions in most biological systems. 
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